Soundbites: Models and Tools

The COMPASS model was developed to predict long-term outcomes based on treatment exposures and age-related risks in 5-year survivors of childhood cancer diagnosed and treated between 1970 and 1999. This model provides insight into survivor health risks compared to the general population with a goal of informing coordinated care.

Microsimulation models used to evaluate the cost-effectiveness of novel cervical cancer screening technologies rely on accurate human papillomavirus (HPV) transition risks. To inform the refinement of such models, authors compared the early natural history of HPV types using three large prospective studies of immunocompetent women.
Authors propose a new health decision modeling framework to evaluate novel cervical screening technologies. The framework de-emphasizes previously used cytologic-colposcopic-histologic diagnoses, relying instead on HPV type and duration of infection as the major determinants of model transition probabilities.